Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vopr Onkol ; 36(5): 587-91, 1990.
Article in Russian | MEDLINE | ID: mdl-2378082

ABSTRACT

The paper discusses the results of treatment of 152 cases of cancer of the esophagus and proximal part of the stomach presenting with grade III-IV dysphagia. In 107 patients, treatment included endoscopic laser coagulation of tumor: in 52 the procedure was combined with radiation and in 18 cases-with chemotherapy, whereas in 37 patients the method was used alone for palliation only attempting at return to enteral nutrition. Histories of 45 patients with esophageal cancer who had received standard treatment served as control. Laser coagulation-associated lethality was 1.9%. Normal food passage was restored in 97.6% of esophageal cancer patients and in 96% of those with cancer of the proximal part of the stomach. The mean overall survival was 8.7, 8.4 and 7.3 months for the study groups and 3.2 months only for controls. The mean dysphagia-free survival was 48.5 days.


Subject(s)
Adenocarcinoma/surgery , Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Esophagoscopy , Light Coagulation , Stomach Neoplasms/surgery , Adenocarcinoma/complications , Carcinoma, Squamous Cell/complications , Deglutition Disorders/etiology , Deglutition Disorders/surgery , Esophageal Neoplasms/complications , Esophagoscopes , Female , Humans , Light Coagulation/instrumentation , Male , Middle Aged , Postoperative Complications/epidemiology , Stomach Neoplasms/complications
2.
Vopr Onkol ; 36(1): 72-6, 1990.
Article in Russian | MEDLINE | ID: mdl-2305567

ABSTRACT

The paper discusses application of endoscopic electrothermocoagulation in complex treatment of inoperable cancer of the esophagus and the proximal part of the stomach presenting with severe dysphagia. The study included 247 such patients, with 77.3% having stage IV tumor. 202 cases underwent electrothermocoagulation as a component of the treatment modality whereas 45 received standard therapy (controls). The newly-developed procedure assured enteral nutrition in 95.4% of cases and a drop in treatment--related complication rate from 33 to 9.3%. Survival ranged 8.4-11.2 months in different study groups and was as low as 3.1 months in controls.


Subject(s)
Electrocoagulation , Esophageal Neoplasms/surgery , Stomach Neoplasms/surgery , Aged , Antineoplastic Agents/therapeutic use , Combined Modality Therapy , Endoscopy , Esophageal Neoplasms/mortality , Esophageal Neoplasms/radiotherapy , Evaluation Studies as Topic , Female , Humans , Male , Middle Aged , Stomach Neoplasms/mortality , Stomach Neoplasms/radiotherapy
SELECTION OF CITATIONS
SEARCH DETAIL
...